Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin

NCT00230854 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C
Hepatitis, Viral, Human

Interventions

DRUG: EMZ702

Sponsor

OPKO Health, Inc.